Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Genotypic characteristics of Mycobacterium tuberculosis isolated from household contacts of tuberculosis patients in the Philippines

  • Irene G Sia6,
  • Seanne P Buckwalter1,
  • Kelly A Doerr1,
  • Sonia Lugos2,
  • Rebecca Kramer2,
  • Ruth Orillaza-Chi3,
  • Maria Imelda Quelapio4,
  • Thelma E Tupasi4, 5 and
  • Nancy L Wengenack1Email author
BMC Infectious Diseases201313:571

DOI: 10.1186/1471-2334-13-571

Received: 18 June 2013

Accepted: 27 November 2013

Published: 5 December 2013

Abstract

Background

The Philippines has an extremely high rate of tuberculosis but little is known about M. tuberculosis genotypes and transmission dynamics in this country. The aim of this study was to determine the proportion of household contacts who develop active TB due to direct transmission from an index case in that household.

Methods

Mycobacterium tuberculosis isolates from household contacts of tuberculosis patients in the Philippines were characterized using restriction-fragment-length polymorphism analysis, spoligotyping, and mycobacterial interspersed repetitive units – variable number tandem repeats typing (12-loci) to determine their utility in elucidating transmission in an area of high tuberculosis prevalence. Drug susceptibility patterns for these isolates were also determined.

Results

Spoligotyping and MIRU-VNTR typing results matched in 10 (62.5%) of 16 index patient-household contact pairs while IS6110 fingerprints matched in only six (37.5%) pairs. Only 3/16 (18.8%) index patient-household contact pairs had identical drug susceptibility results.

Conclusions

Strain typing of M. tuberculosis isolates from household contacts in the Philippines indicates that transmission of strains does not necessarily occur directly from the index patient living in close proximity in the same household but rather that community-based transmission also frequently occurs. Accurate susceptibility testing of all isolates is necessary to insure optimal care of both the index patients and any culture-positive household contacts.

Background

Tuberculosis (TB) is a serious global health problem, with the largest number of cases disproportionately occurring in developing countries. The Philippines is one of the countries hardest hit by the disease, with the second highest TB incidence in Asia [1]. We previously reported a remarkably high prevalence of 12.8% for TB disease and 65.6% for TB infection among household contacts of tuberculosis patients in the Philippines [2]. The Philippines also bear a significant proportion of the global multidrug resistant (MDR) TB burden [3, 4]. Although the Philippines have an extremely high rate of TB, little is known about M tuberculosis genotype and transmission dynamics in this country. The aim of this study was to determine the proportion of household contacts who develop active TB due to direct transmission from an index case in that household.

Molecular genotyping has advanced the understanding of M tuberculosis transmission and is helpful in identifying transmission links in a community. Restriction fragment-length polymorphism (RFLP) analysis of the insertion sequence 6110 (IS6110) is often used for genotyping of M tuberculosis. However, molecular characterization using RFLP method is laborious and requires culture for several weeks to obtain large quantities of genomic DNA. In addition, RFLP has poor discriminatory power for isolates with low numbers of insertion sites [5]. The development of PCR-based typing methods has enabled rapid mycobacterial genotyping [6, 7]. Spacer oligonucleotide typing (spoligotyping) is a rapid PCR-based method that examines DNA polymorphisms at the unique direct repeat (DR) region of M tuberculosis. It is easier to perform and requires smaller amounts of DNA than RFLP analysis but its discriminatory capacity is inferior to RFLP. Spoligotyping is useful in discriminating strains with low IS6110 copy numbers and it can be performed on nonviable organisms. Mycobacterial interspersed repetitive units (MIRU) – variable number tandem repeats (VNTR) is another PCR-based method that is easily reproducible and does not require extensive DNA purification. MIRU-VNTR [8] has become a major method for rapid, high-resolution genotyping of M tuberculosis complex isolates. The method relies on PCR amplification of multiple loci (12, 15 or 24 loci) using primers specific for the flanking regions of each repeat locus and on the determination of the sizes of the amplicons, which reflect the numbers of the targeted MIRU-VNTR copies [9]. Moreover, the results are expressed as numerical codes and are therefore easy to compare and exchange between laboratories [10].

Only a limited number of M tuberculosis isolates from the Philippines have been genotyped [11, 12]; no studies have described the epidemiologic links among isolates. The aims of this study were to characterize M tuberculosis isolated from TB patients in Philippine households using three methods for genotyping, namely RFLP, spoligotyping, and MIRU-VNTR, and to describe the transmission and drug susceptibility patterns of these isolates.

Methods

Study isolates

Sputum for acid-fast bacilli (AFB) smear microscopy and culture were collected from the index case (IC) and household contact (HC) cases during a contact investigation study on sputum smear-positive TB patients seen at the Tropical Disease Foundation DOTS Clinic, Makati Medical Center, Metro Manila between 2001 and 2003 [2, 13]. Two hundred eighteen index cases aged ≥18 years with sputum smear-positive TB, including 163 (74.8%) with MDR-TB, were identified. Eight hundred ninety seven of their household contacts were evaluated for TB with tuberculin skin test, chest x-ray and sputum examination. One hundred thirteen (12.8%) household contacts with TB were identified by positive chest x-rays and/or positive sputum results; of these, 20 were sputum culture-positive. A total of 29 M tuberculosis paired isolates were available from 13 index patients and 16 household contacts. Patients were between the ages of 10 and 60 (mean, 31) years; eight were females, 21 were males.

All sputum specimens were first processed and cultured on Lowenstein-Jensen slants and strain identification was performed in the Philippines using the nitrate and niacin tests according to established protocols [14]. The identification of the isolates was confirmed in the United States prior to genotyping studies using a nucleic acid hybridization probe specific for M. tuberculosis complex (GenProbe AccuProbe®, San Diego, CA). Antimicrobial susceptibility testing was performed in the Philippines and confirmed in the United States using Clinical and Laboratory Standards Institute guidelines [15] with the 1% indirect agar proportion method used for all antimicrobial agents except pyrazinamide. Pyrazinamide was tested using the VersaTREK broth system (TREK Diagnostics, Cleveland, OH). Isolates were genotyped using RFLP IS6110 fingerprinting [5], spoligotyping [6] and 12-loci MIRU-VNTR typing [16] as previously described.

Ethics statement

The study was approved by the Institutional Review Boards of Mayo Clinic Rochester and the Tropical Disease Foundation - Makati Medical Center. Written informed consent was obtained from all patients, adult household contacts, and/or head of household.

Results

Genotyping

IS6110 fingerprinting, spoligotyping and 12-loci MIRU-VNTR typing were done on 29 M tuberculosis isolates from 13 households in the Philippines (Table 1). One household had three household contacts with TB; another household had two contacts with TB. Altogether, there were 16 paired IC-HC isolates. Genotyping found 23 IS6110 fingerprints, 9 spoligotypes, and 13 MIRU-VNTR types.
Table 1

IS6110 Restriction fragment length polymorphism (RFLP), spoligotyping, and mycobacterial interspersed repetitive unit variable numbers of tandem repeat (MIRU-VNTR) typing patterns of Mycobacterium tuberculosis isolates from index case (IC) and household contact (HC) cases from the Philippines

Household/index group

RFLP Pattern

Spoligotype pattern

MIRU-VNTR Code

Lineage/family

Methods with matching paired IC-HC

DST match?

  

1 Spacer # 43

    

IC1

5–13

■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■

244336223432

Manila

  

HC1

5–13

■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■

244336223432

Manila

RFLP/Spoligo/MIRU

No

IC2

10–14

■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■

254326223432

Manila

  

HC2

34–13

■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■

254326223432

Manila

Spoligo/MIRU

No

IC3

2–13

■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ □□□ □□□ □□■ ■■■ ■■■ ■

254326223432

ND

  

HC3

2–13

■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ □□□ □□□ □□■ ■■■ ■■■ ■

254326223432

ND

RFLP/Spoligo/MIRU

No

IC4

35–11

■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■

254326223422

Manila

  

HC4

3–12

■■□ ■■■ ■■■ ■■■ ■□□ □■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■

254326223432

ND

None

No

IC5

1–13

■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■

254326223332

Manila

  

HC5

1–13

■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■

254326223332

Manila

RFLP/Spoligo/MIRU

Yes

IC6

11–15

■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■

234326223432

Manila

  

HC6.1

4–16

■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■

234326223432

Manila

Spoligo/MIRU (IC6/HC6.1)

No

HC6.2

6–14

■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■

234326223432

Manila

Spoligo/MIRU (IC6/HC6.2)

No

HC6.3

7–13

□■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □□□ ■■■ ■■■ ■

253326223432

ND

None (IC6/HC6.3)

No

IC7

19–12

■■□ ■■■ ■□□ □□□ □□□ □□□ □□□ □□□ □□□ □□□ □□□ □□□ □□■ ■■■ ■

254326223432

ND

  

HC7.1

20–13

■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■

254326223432

Manila

MIRU (IC7/HC7.1)

No

HC7.2

18–11

■■□ ■■■ □■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □□■ □■■ ■■■ ■

274326223432

ND

None (IC7/HC7.1)

No

IC8

12–15

■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■

234326223432

Manila

  

HC8

37–13

■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■

254326223432

Manila

Spoligo

No

IC9

14–19

□□□ □□□ □□□ □□□ □□□ □□□ □□□ □□□ □□□ □□□ □□□ □■■ ■■■ ■■■ ■

223325173533

Beijing

  

HC9

14–19

□□□ □□□ □□□ □□□ □□□ □□□ □□□ □□□ □□□ □□□ □□□ □■■ ■■■ ■■■ ■

223325173533

Beijing

RFLP/Spoligo/MIRU

Yes

IC10

27–12

■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■

254326223422

Manila

  

HC10

27–12

■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■

254326223422

Manila

RFLP/Spoligo/MIRU

Yes

IC11

25–15

■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ □□□ □□□ □□□ □□□ □□□ □□□ □

254326224332

ND

  

HC11

23–12

■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■

254326223432

ND

MIRU

No

IC12

32–11

■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■■□ □□□ □□□ □□□ ■■□ □□□ ■■■ ■■■ ■

224227163221

ND

  

HC12

28–13

■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■■□ □□□ □□□ □□□ ■■□ □□□ ■■■ ■■■ ■

224227163321

ND

Spoligo/MIRU

No

IC13

29–11

■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■

354326223422

Manila

  

HC13

29–11

■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■

354326223422

Manila

RFLP/Spoligo/MIRU

No

RFLP = restriction fragment length polymorphism; Spoligo = spligotyping; MIRU = multiple interspersed repeating units/variable number tandem repeats; ND = not determined; IC = index case; HC = household contact patient, DST = drug susceptibility.

When known, lineage information is listed.

Isolates had between 11 and 19 (median, 13) copies of IS6110 by RFLP. By spoligotyping, two isolates from one household (Table 1, IC9 and HC9) had the Beijing genotype and 17 (58.6%) of isolates from nine households lacked eight spacers characteristic of the Manila family [12].

Spoligotyping and MIRU-VNTR typing both matched in 10 (62.5%) of 16 pairs while IS6110 fingerprints matched in only six (37.5%) IC-HC pairs. All six pairs with matching IS6110 fingerprints also matched by spoligotypes and MIRU-VNTR types. Three paired isolates matched by only one genotyping method, and the remaining three pairs had genotypes that were different by all three fingerprinting methods.

Drug susceptibility testing

Results of drug susceptibility testing are shown in Table 2. Only four of the 29 (13.8%) isolates were fully susceptible to all first line drugs; eight (27.6%) were resistant to all first line drugs. Isoniazid (INH) resistance was detected in 24/29 (82.8%) and 19/29 (65.5%) at low (0.2 μg/ml) and high (1.0 μg/ml) concentrations, respectively. Resistance to rifampin (RIF), ethambutol (EMB) and pyrazinamide (PZA) occurred in 19/29 (65.5%), 14/29 (48.3%), and 9/28 (32.1%), respectively. There were 19 (65.5%) MDR M tuberculosis isolates. With second line drugs, resistance to streptomycin (STR) at 2.0 μg/ml, streptomycin at 10 μg/ml, capreomycin (CAP), and ethionamide (ETH) was detected in 16/29 (55.2%), 13/29 (44.8%), 3/29 (10.3%), and 6/29 (20.7%), respectively. Resistance to kanamycin (KAN), amikacin (AMI), cycloserine (CYC) and para-aminosalicylic acid (PAS) was not detected. Because resistance testing to fluoroquinolones was not performed, the number of extensively-drug resistant isolates is not known.
Table 2

Drug susceptibilities of Mycobacterium tuberculosis isolates from index case (IC) and household contact (HC) cases in the Philippines

 

First line drugs a

Second line drugs

Household/index contacts

INH

RIF

EMB

PZA

STR

CAP

KAN

AMI

ETH

CYC

PAS

 

0.2

1.0

1.0

7.5

300

2.0

10

10

6.0

6.0

10

60.0

8.0

IC1

R

R

R

R

R

S

S

S

S

S

S

S

S

HC1

R

R

S

S

S

S

S

S

S

S

S

S

S

IC2

R

R

R

R

R

R

R

S

S

S

S

S

S

HC2

R

R

R

S

S

R

R

S

S

S

S

S

S

IC3

R

S

R

S

S

R

R

S

S

S

S

S

S

HC3

R

R

R

S

S

S

S

S

S

S

S

S

S

IC4

R

R

R

S

N/A b

R

S

S

S

S

R

S

S

HC4

R

R

S

S

S

R

S

S

S

S

S

S

S

IC5

R

R

R

R

R

R

R

S

S

S

S

S

S

HC5

R

R

R

R

R

R

R

S

S

S

S

S

S

IC6

R

R

R

R

R

R

R

S

S

S

R

S

S

HC6.1

R

R

R

R

S

R

R

S

S

S

R

S

S

HC6.2

R

R

R

R

S

R

R

S

S

S

R

S

S

HC6.3

S

S

S

S

S

S

S

S

S

S

S

S

S

IC7

R

S

R

R

S

R

R

S

S

S

R

S

S

HC7.1

S

S

S

S

S

S

S

S

S

S

S

S

S

HC7.2

S

S

S

S

S

S

S

S

S

S

S

S

S

IC8

R

S

S

S

S

S

S

S

S

S

S

S

S

HC8

S

S

S

S

R

S

S

S

S

S

S

S

S

IC9

R

R

R

R

R

R

R

S

S

S

S

S

S

HC9

R

R

R

R

R

R

R

S

S

S

S

S

S

IC10

R

S

S

S

S

S

S

S

S

S

S

S

S

HC10

R

S

S

S

S

S

S

S

S

S

S

S

S

IC11

S

S

S

S

S

S

S

S

S

S

S

S

S

HC11

R

R

R

S

S

S

S

R

S

S

R

S

S

IC12

R

R

R

R

R

R

R

R

S

S

S

S

S

HC12

R

R

R

R

S

R

R

R

S

S

S

S

S

IC13

R

R

R

R

S

R

S

S

S

S

S

S

S

HC13

R

R

R

R

S

S

S

S

S

S

S

S

S

Susceptibilities are reported in μg/mL.

Abbreviations: INH – isoniazid, RIF – rifampin, EMB – ethambutol, PZA – pyrazinamide, STR – streptomycin, CAP – capreomycin, KAN – kanamycin, AMI – amikacin, ETH – ethionamide, CYC – cycloserine, PAS – para-aminosalicylic acid; R – resistant, S – susceptible.

a With the exception of PZA, susceptibility for all drugs was performed by the 1% indirect agar proportion method. PZA susceptibility was performed on the VersaTREK (TREK Diagnostics, Cleveland, OH).

b Isolate unable to grow in test medium for PZA susceptibility testing.

Comparing test results of paired IC-HC isolates, only 3/16 (18.8%) had identical drug susceptibility results. In one household with four cases of TB (IC6), only two isolates had the same susceptibility pattern. Both isolates with the Beijing genotype were multidrug resistant, whereas 11 of 17 (64.7%) isolates with the Manila genotype were multidrug resistant.

Discussion

DNA fingerprinting of M tuberculosis has transformed our understanding of the transmission of TB and provides a tool for the identification of transmission patterns. We sought to better understand TB transmission in the Philippines, which has a high TB and MDR TB burden, by molecular characterization of M tuberculosis isolates from household contacts of TB cases. Using three genotyping methods, our results show that based on the highest level of discrimination by IS6110 fingerprinting, approximately two-thirds (10/16, 62.5%) of TB in household contacts may have been acquired from a source outside of the household. A number of studies have elucidated that household contacts of TB patients have a higher risk of being infected [1720]. In high TB prevalence setting, there are multiple sources of infection and numerous opportunities for TB transmission as a result of social mixing [21].

In Capetown, South Africa, where TB is highly endemic, RFLP analysis of 313 isolates from 129 households showed matching fingerprints in only 46%; the authors estimated that proportion of TB transmission occurring in household is only 19% [22]. Metro Manila is the largest city in the Philippines, with a population of over 11 million people, and a large number of urban poor settlements where TB is a substantial problem [23]. We analyzed M tuberculosis isolates that were collected from index and household contact TB cases in Metro Manila. IS6110 genotypes from household contacts matched those of index cases in six of 16 (37.5%). In the two households with more than two TB cases (IC6 and IC7), none of the isolates from the same household matched in IS6110 fingerprint. The fact that individuals with TB from the same household are infected with different strains of M tuberculosis suggests that the infection was acquired from outside the household, and most likely reflects the TB burden in the community.

Very few studies have been done to molecularly characterize M tuberculosis isolates from the Philippines. Analysis of 40 randomly collected isolates from the Philippines revealed that 38 of isolates had 80% or greater similarity, but non-identical, IS6110 fingerprints; these isolates has been given the designation as the Manila family [12]. In another study, 33 of 34 (97.0%) isolates from the Philippines also collected at random, showed similar but distinct IS6110 fingerprints [11]. These isolates had more than eight copies of IS6110, most having 13 copies. Our findings corroborate the presence of different strains of M tuberculosis with 11 or greater copies of IS6110 circulating in the community.

Spoligotyping of 48 M tuberculosis isolates from Manila showed patterns that were highly similar; 41/48 (85.4%) had identical patterns lacking hybridization to eight spacers [12]. These isolates have been classified as the Manila family. In our study on 29 isolates, 17 (58.6%) lacked hybridization to these spacers.

In The Gambia, spoligotyping on nine paired index-household cases revealed six (66.6%) pairs to match and three (33.3%) that were unmatched [24]. Our results showed a similar rate of spoligotype matching in 11 of 16 (68.8%) pairs. In the Philippines where most isolates of M tuberculosis have ≥8 copies of IS6110 [12], spoligotyping does not appear to be sufficiently discriminatory as an epidemiologic tool. We detected the same number of matched isolates (11/16) with MIRU-VNTR as spoligotyping.

IS6110 RFLP typing [25] has been replaced in some settings with easier-to-perform, alternative PCR-based strategies, such as spoligotyping and MIRU-VNTR. These alternative typing methods, with classical epidemiological investigations, are being internationally adopted as the new reference method for TB molecular epidemiology [26, 27]. A recent population-based study indicated that the use of MIRU-VNTR system as a first-line method in combination with spoligotyping provides adequate discrimination in most cases for large-scale, prospective genotyping of M. tuberculosis in the United States [28]. However, IS6110 fingerprinting is still useful as an additional method to type the clustered isolates in a number of cases. The combination of these two PCR-based typing methods may be useful in low TB prevalence settings [28], but its utility in high TB prevalence settings has yet to be clearly demonstrated. In our sample of 16 paired isolates for example, the combination of spoligotyping and MIRU-VNTR typing matched 10 pairs of isolates, whereas IS6110 fingerprinting further discriminated the isolates into only six matching pairs.

We tested a high number of MDR M tuberculosis isolates; this was expected since we identified patients at a referral center for treatment of MDR TB [29]. Comparing fingerprint data with drug susceptibility results, only three of the six (50.0%) pairs with identical genotypes had matching drug susceptibility. There were no observable patterns in terms of the matched isolates being from a particular type of household relationship (eg., the young child or the partner of an index case) or in the length of time between diagnosis of the index patient and the household contact(s) (Table 3). Since 10 of 13 index patients had MDR-TB, we were unable to determine whether MDR-TB patients were more likely to transmit TB to a household contact than the non-MDR index patients. These finding have implications in the treatment of TB and highlight the importance of drug susceptibility testing; treatment of TB in household contacts cannot be inferred from drug susceptibility of M tuberculosis of index patients.
Table 3

Patient demographics

Index patient/ pousehold contact(s)

Year diagnosed with tuberculosis

Years between diagnosis

Age at diagnosis

Sex

Relationship

DST matches? (Y/N)

Genotyping match?a(Y/N)

IC1

2001

 

41

F

   

HC1

2001

0

22

F

child

N

Y

IC2

2001

 

28

M

   

HC2

2001

0

18

M

sibling

N

N

IC3

2001

 

52

M

   

HC3

NA

NA

22

F

child

N

Y

IC4

2001

 

38

M

   

HC4

2001

0

10

M

child

N

N

IC5

2001

 

42

M

   

HC5

2001

0

22

M

child

Y

Y

IC6

2002

 

17

M

   

HC6.1

2002

0

20

M

sibling

N

N

HC6.2

2002

0

29

M

sibling

N

N

HC6.3

2002

0

22

M

sibling

N

N

IC7

2002

 

43

M

   

HC7.1

2002

0

33

F

sibling

N

N

HC7.2

NA

NA

41

M

sibling

N

N

IC8

2001

 

28

F

   

HC8

2007

6

60

M

parent

N

N

IC9

2001

 

19

M

   

HC9

2003

2

30

M

sibling

Y

Y

IC10

2000

 

40

M

   

HC10

2003

3

40

F

sibling

Y

Y

IC11

2003

 

NA

M

   

HC11

2004

1

NA

M

NA

N

N

IC12

2003

 

30

F

   

HC12

2004

1

28

F

sibling

N

N

IC13

2003

 

49

M

   

HC13

2008

5

32

M

child

N

Y

DST = drug susceptibility testing, NA = not available, Y = yes, N = no.

aUsing all 3 methods (spoligotyping, MIRU-VNTR and RLFP).

Our study has some limitations. We tested only a small number of isolates, and samples were collected from a TB referral center in one geographic area in the Philippines. Our results may not reflect the predominantly circulating strains of M tuberculosis in the general population. Lately, MIRU-VNTR typing of 15 or 24 loci has been applied to molecular typing of M tuberculosis; we may have found more genetic diversity in our samples with 24-loci method than with the 12-loci method used in this study. Nonetheless, our data demonstrate that there is significant genotype and drug susceptibility diversity within households with multiple cases of tuberculosis.

Conclusions

Patients in high TB burden regions are exposed to TB outside the home, and therefore may be infected by source patients outside the home. Genotyping of M tuberculosis from the Philippines will aid in understanding the epidemiology of TB of this country, which can lead to improved strategies to reduce TB prevalence in the country.

Our results augment the findings from other studies that in highly prevalent areas, TB transmission is as likely to occur in the community as it is within the household. Furthermore, our data highlights the importance of drug susceptibility testing particularly for household contacts of MDR TB patients to ensure that they receive the appropriate drugs to which their isolates are susceptible. Our results have significant implications to TB control in the Philippines. Strain typing of TB provides valuable information on the number and type of strains circulating in a community; more importantly, it provides information on the transmission, which informs prevention and control. Further studies on a larger number of isolates are needed to properly elucidate the epidemiology and transmission of TB in this country.

Declarations

Authors’ Affiliations

(1)
Department of Laboratory Medicine and Pathology, Mayo Clinic
(2)
Michigan Department of Community Health, Lansing
(3)
University of the Philippines and Philippine General Hospital
(4)
Tropical Disease Foundation
(5)
Makati Medical Center
(6)
Division of Infectious Diseases, Mayo Clinic

References

  1. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, Dye C: The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med. 2003, 163 (9): 1009-1021. 10.1001/archinte.163.9.1009.View ArticlePubMedGoogle Scholar
  2. Sia I, Orillaza R, St Sauver J, Quelapio I, Lahr B, Alcaneses R, Wilson W, Cockerill F, Balane G, Mangubat N, et al: Tuberculosis attributed to household contacts in the Philippines. Int J Tuberc Lung Dis. 2010, 14 (1): 122-125.PubMedGoogle Scholar
  3. WHO: Global Tuberculosis Control Report. 2012, Geneva, Switzerland: World Health OrganizationGoogle Scholar
  4. Peabody JW, Shimkhada R, Tan C, Luck J: The burden of disease, economic costs and clinical consequences of tuberculosis in the Philippines. Health Policy Plan. 2005, 20 (6): 347-353. 10.1093/heapol/czi041.View ArticlePubMedGoogle Scholar
  5. Daley CL: Molecular epidemiology: a tool for understanding control of tuberculosis transmission. Clin Chest Med. 2005, 26 (2): 217-231. 10.1016/j.ccm.2005.02.005. viView ArticlePubMedGoogle Scholar
  6. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S, Bunschoten A, Molhuizen H, Shaw R, Goyal M, et al: Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol. 1997, 35 (4): 907-914.PubMedPubMed CentralGoogle Scholar
  7. van Soolingen D, de Haas PE, Hermans PW, Groenen PM, van Embden JD: Comparison of various repetitive DNA elements as genetic markers for strain differentiation and epidemiology of Mycobacterium tuberculosis. J Clin Microbiol. 1993, 31 (8): 1987-1995.PubMedPubMed CentralGoogle Scholar
  8. Mazars E, Lesjean S, Banuls AL, Gilbert M, Vincent V, Gicquel B, Tibayrenc M, Locht C, Supply P: High-resolution minisatellite-based typing as a portable approach to global analysis of Mycobacterium tuberculosis molecular epidemiology. Proc Natl Acad Sci USA. 2001, 98 (4): 1901-1906. 10.1073/pnas.98.4.1901.View ArticlePubMedPubMed CentralGoogle Scholar
  9. Frothingham R, Meeker-O'Connell WA: Genetic diversity in the Mycobacterium tuberculosis complex based on variable numbers of tandem DNA repeats. Microbiology. 1998, 144 (Pt 5): 1189-1196.View ArticlePubMedGoogle Scholar
  10. Allix C, Supply P, Fauville-Dufaux M: Utility of fast mycobacterial interspersed repetitive unit-variable number tandem repeat genotyping in clinical mycobacteriological analysis. Clin Infect Dis. 2004, 39 (6): 783-789. 10.1086/423383.View ArticlePubMedGoogle Scholar
  11. Park YK, Bai GH, Kim SJ: Restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolated from countries in the western pacific region. J Clin Microbiol. 2000, 38 (1): 191-197.PubMedPubMed CentralGoogle Scholar
  12. Douglas JT, Qian L, Montoya JC, Musser JM, Van Embden JD, Van Soolingen D, Kremer K: Characterization of the Manila family of Mycobacterium tuberculosis. J Clin Microbiol. 2003, 41 (6): 2723-2726. 10.1128/JCM.41.6.2723-2726.2003.View ArticlePubMedPubMed CentralGoogle Scholar
  13. Salazar-Vergara RM, Sia IG, Tupasi TE, Alcaneses MR, Orillaza RB, Co V, Quelapio MI, Beltran G, Legaspi JD, Rostrata MP, et al: Tuberculosis infection and disease in children living in households of Filipino patients with tuberculosis: a preliminary report. Int J Tuberc Lung Dis. 2003, 7 (12 Suppl 3): S494-S500.PubMedGoogle Scholar
  14. Kent PT, Kubica GP: Public health mycobacteriology: a guide for the level III laboratory. 1985, Centers for Disease Control and Prevention: Atlanta, GAGoogle Scholar
  15. CLSI: Susceptibility Testing of Mycobacteria, Nocardia and Other Aerobic Actinomycetes - Second Edition. 2011, 950 West Valley Road, Suite 2500 Wayne, PA 19087 USA: Clinical and Laboratory Standards InstituteGoogle Scholar
  16. de Beer J, Kremer K, Kodmon C, Supply P, Van Soolingen D, Augustynowicz-Kopec E, Bidovec Stojkovic U, Boeree M, Brown T, Cirillo D, et al: First worldwide proficiency study on variable-number tandem-repeat typing of Mycobacterium tuberculosis complex strains. J Clin Microbiol. 2012, 50 (3): 662-669. 10.1128/JCM.00607-11. Epub 2011 Dec 2014View ArticlePubMedPubMed CentralGoogle Scholar
  17. Shaw J, Wynn-Williams N: Infectivity of pulmonary tuberculosis in relation to sputum status. Am Rev Tuberc Respir Dis. 1954, 69: 724-732.Google Scholar
  18. Lutong L, Bei Z: Association of prevalence of tuberculin reactions with closeness of contact among household contacts of new smear-positive pulmonary tuberculosis patients. Int J Tuberc Lung Dis. 2000, 4 (3): 275-277.PubMedGoogle Scholar
  19. Fuimaono A, Vince J: Screening contacts of children with tuberculosis: an important and worthwhile part of case management. P N G Med J. 1997, 40 (2): 69-73.PubMedGoogle Scholar
  20. Beyers N, Gie RP, Schaaf HS, Van Zyl S, Talent JM, Nel ED, Donald PR: A prospective evaluation of children under the age of 5 years living in the same household as adults with recently diagnosed pulmonary tuberculosis. Int J Tuberc Lung Dis. 1997, 1 (1): 38-43.PubMedGoogle Scholar
  21. Classen CN, Warren R, Richardson M, Hauman JH, Gie RP, Ellis JH, van Helden PD, Beyers N: Impact of social interactions in the community on the transmission of tuberculosis in a high incidence area. Thorax. 1999, 54 (2): 136-140. 10.1136/thx.54.2.136.View ArticlePubMedPubMed CentralGoogle Scholar
  22. Verver S, Warren RM, Munch Z, Richardson M, van der Spuy GD, Borgdorff MW, Behr MA, Beyers N, van Helden PD: Proportion of tuberculosis transmission that takes place in households in a high-incidence area. Lancet. 2004, 363 (9404): 212-214. 10.1016/S0140-6736(03)15332-9.View ArticlePubMedGoogle Scholar
  23. Tupasi TE, Radhakrishna S, Quelapio MI, Villa ML, Pascual ML, Rivera AB, Sarmiento A, Co VM, Sarol JN, Beltran G, et al: Tuberculosis in the urban poor settlements in the Philippines. Int J Tuberc Lung Dis. 2000, 4 (1): 4-11.PubMedGoogle Scholar
  24. Hill PC, Jackson-Sillah DJ, Fox A, Brookes RH, de Jong BC, Lugos MD, Adetifa IM, Donkor SA, Aiken AM, Howie SR, et al: Incidence of tuberculosis and the predictive value of ELISPOT and Mantoux tests in Gambian case contacts. PLoS One. 2008, 3 (1): e1379-10.1371/journal.pone.0001379.View ArticlePubMedPubMed CentralGoogle Scholar
  25. van Embden JD, Cave MD, Crawford JT, Dale JW, Eisenach KD, Gicquel B, Hermans P, Martin C, McAdam R, Shinnick TM, et al: Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol. 1993, 31 (2): 406-409.PubMedPubMed CentralGoogle Scholar
  26. Supply P, Allix C, Lesjean S, Cardoso-Oelemann M, Rusch-Gerdes S, Willery E, Savine E, de Haas P, van Deutekom H, Roring S, et al: Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J Clin Microbiol. 2006, 44 (12): 4498-4510. 10.1128/JCM.01392-06.View ArticlePubMedPubMed CentralGoogle Scholar
  27. Oelemann MC, Diel R, Vatin V, Haas W, Rusch-Gerdes S, Locht C, Niemann S, Supply P: Assessment of an optimized mycobacterial interspersed repetitive- unit-variable-number tandem-repeat typing system combined with spoligotyping for population-based molecular epidemiology studies of tuberculosis. J Clin Microbiol. 2007, 45 (3): 691-697. 10.1128/JCM.01393-06.View ArticlePubMedGoogle Scholar
  28. Cowan LS, Diem L, Monson T, Wand P, Temporado D, Oemig TV, Crawford JT: Evaluation of a two-step approach for large-scale, prospective genotyping of Mycobacterium tuberculosis isolates in the United States. J Clin Microbiol. 2005, 43 (2): 688-695. 10.1128/JCM.43.2.688-695.2005.View ArticlePubMedPubMed CentralGoogle Scholar
  29. Tupasi TE, Quelapio MI, Orillaza RB, Alcantara C, Mira NR, Abeleda MR, Belen VT, Arnisto NM, Rivera AB, Grimaldo ER, et al: DOTS-Plus for multidrug-resistant tuberculosis in the Philippines: global assistance urgently needed. Tuberculosis (Edinb). 2003, 83 (1–3): 52-58.View ArticleGoogle Scholar
  30. Pre-publication history

    1. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/13/571/prepub

Copyright

© Sia et al.; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.